Adherence to early pulmonary rehabilitation after COPD exacerbation and risk of hospital readmission: a secondary analysis of the COPD-EXA-REHAB study.
COPD exacerbations
exercise
pulmonary rehabilitation
Journal
BMJ open respiratory research
ISSN: 2052-4439
Titre abrégé: BMJ Open Respir Res
Pays: England
ID NLM: 101638061
Informations de publication
Date de publication:
08 2020
08 2020
Historique:
received:
26
02
2020
revised:
24
07
2020
accepted:
24
07
2020
entrez:
21
8
2020
pubmed:
21
8
2020
medline:
11
6
2021
Statut:
ppublish
Résumé
Early pulmonary rehabilitation after exacerbation of chronic obstructive pulmonary disease (COPD) has previously been shown to reduce the risk of hospital admission and improve physical performance and quality of life. However, the impact of attendance at early rehabilitation programmes has not been established. To evaluate the impact of increasing attendance to pulmonary rehabilitation on the risk of hospital admission, physical performance and quality of life in patients attending an early rehabilitation programme after an exacerbation of COPD. This study was a secondary exploratory analysis of the randomised controlled trial COPD-EXA-REHAB study, involving patients hospitalised with an exacerbation of COPD. The COPD-EXA-REHAB study compared early pulmonary rehabilitation, starting within 2 weeks after an exacerbation, with standard treatment, that is, the same programme starting 2 months later. The present analysis included only the 70 patients allocated to early pulmonary rehabilitation. At 1-year follow-up, we found an association between the number of sessions attended and a reduction in hospital admissions (incidence rate ratio 0.93 (95% CI 0.88 to 0.99), p=0.02), corresponding to a 7% reduction for each session attended. Similarly, at 2-month follow-up, physical performance was positively associated with sessions attended: the mean Incremental Shuttle Walk Test result improved by 8 m with each session (95% CI 2.54 to 13.56, p=0.005) and the Endurance Shuttle Walk Test result by 44 s (95% CI 18.41 to 68.95, p=0.001). Quality of life, assessed using the COPD Assessment Test, was not significantly associated with the number of attended sessions, with the average score increasing by 0.15 points with each session (95% CI -0.35 to 0.65, p=0.55). Increased attendance at early pulmonary rehabilitation after exacerbation of COPD was associated with reduced risk of hospital admission and improved physical performance.
Sections du résumé
BACKGROUND
Early pulmonary rehabilitation after exacerbation of chronic obstructive pulmonary disease (COPD) has previously been shown to reduce the risk of hospital admission and improve physical performance and quality of life. However, the impact of attendance at early rehabilitation programmes has not been established.
OBJECTIVES
To evaluate the impact of increasing attendance to pulmonary rehabilitation on the risk of hospital admission, physical performance and quality of life in patients attending an early rehabilitation programme after an exacerbation of COPD.
METHODS
This study was a secondary exploratory analysis of the randomised controlled trial COPD-EXA-REHAB study, involving patients hospitalised with an exacerbation of COPD. The COPD-EXA-REHAB study compared early pulmonary rehabilitation, starting within 2 weeks after an exacerbation, with standard treatment, that is, the same programme starting 2 months later. The present analysis included only the 70 patients allocated to early pulmonary rehabilitation.
RESULTS
At 1-year follow-up, we found an association between the number of sessions attended and a reduction in hospital admissions (incidence rate ratio 0.93 (95% CI 0.88 to 0.99), p=0.02), corresponding to a 7% reduction for each session attended. Similarly, at 2-month follow-up, physical performance was positively associated with sessions attended: the mean Incremental Shuttle Walk Test result improved by 8 m with each session (95% CI 2.54 to 13.56, p=0.005) and the Endurance Shuttle Walk Test result by 44 s (95% CI 18.41 to 68.95, p=0.001). Quality of life, assessed using the COPD Assessment Test, was not significantly associated with the number of attended sessions, with the average score increasing by 0.15 points with each session (95% CI -0.35 to 0.65, p=0.55).
CONCLUSION
Increased attendance at early pulmonary rehabilitation after exacerbation of COPD was associated with reduced risk of hospital admission and improved physical performance.
Identifiants
pubmed: 32816829
pii: 7/1/e000582
doi: 10.1136/bmjresp-2020-000582
pmc: PMC7440705
pii:
doi:
Types de publication
Journal Article
Randomized Controlled Trial
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.
Déclaration de conflit d'intérêts
Competing interests: None declared.
Références
Thorax. 2008 Sep;63(9):775-7
pubmed: 18390634
Int J Chron Obstruct Pulmon Dis. 2017 Dec 20;13:37-44
pubmed: 29302187
Chron Respir Dis. 2015 Feb;12(1):5-10
pubmed: 25511306
Respir Med. 2014 Feb;108(2):319-28
pubmed: 24238773
Cochrane Database Syst Rev. 2015 Feb 23;(2):CD003793
pubmed: 25705944
BMC Pulm Med. 2018 Sep 15;18(1):154
pubmed: 30219047
Respirology. 2013 Oct;18(7):1089-94
pubmed: 23711304
Am J Respir Crit Care Med. 2013 Oct 15;188(8):e13-64
pubmed: 24127811
Chron Respir Dis. 2011;8(2):89-99
pubmed: 21596892
J Physiother. 2017 Apr;63(2):84-93
pubmed: 28433238
Disabil Rehabil. 2015;37(9):750-6
pubmed: 25009949
Cochrane Database Syst Rev. 2016 Dec 08;12:CD005305
pubmed: 27930803
Lancet Respir Med. 2014 Mar;2(3):195-203
pubmed: 24621681
ERJ Open Res. 2020 Feb 17;6(1):
pubmed: 32083113
Respir Res. 2015 Feb 19;16:27
pubmed: 25849109
ERJ Open Res. 2017 Jan 30;3(1):
pubmed: 28154821
Respir Med. 2013 Mar;107(3):401-7
pubmed: 23261311
Physiother Can. 2010 Fall;62(4):368-73
pubmed: 21886377
Clin Respir J. 2011 Oct;5(4):235-44
pubmed: 21324098
Clin Epidemiol. 2010 Aug 09;2:73-83
pubmed: 20865106
Ugeskr Laeger. 2007 Apr 23;169(17):1572-6
pubmed: 17484828
Thorax. 2014 Feb;69(2):181-2
pubmed: 23945168
Clin Respir J. 2010 Oct;4(4):208-14
pubmed: 20887343
Eur Respir J. 2017 Mar 15;49(3):
pubmed: 28298398
Chest. 2016 Oct;150(4):837-859
pubmed: 27497743